367 related articles for article (PubMed ID: 16188399)
1. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
2. Methodology for reorganization of the cervical cancer program in Chile.
Salas I
Cancer Detect Prev; 2006; 30(1):38-43. PubMed ID: 16504420
[TBL] [Abstract][Full Text] [Related]
3. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
5. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
7. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
10. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
Hølund B; Grinsted P
Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
Koong SL; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
[TBL] [Abstract][Full Text] [Related]
12. Review of screening and preventive strategies for cervical cancer in India.
Patro BK; Nongkynrih B
Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
[TBL] [Abstract][Full Text] [Related]
13. Why women still die from cervical cancer.
Masood S
J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
[TBL] [Abstract][Full Text] [Related]
14. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening in Thailand: an overview.
Sriamporn S; Khuhaprema T; Parkin M
J Med Screen; 2006; 13 Suppl 1():S39-43. PubMed ID: 17227641
[TBL] [Abstract][Full Text] [Related]
16. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
Yeoh KG; Chew L; Wang SC
J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
[TBL] [Abstract][Full Text] [Related]
18. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
[TBL] [Abstract][Full Text] [Related]
19. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
20. Screening for cervical cancer: will women accept less?
Sirovich BE; Woloshin S; Schwartz LM
Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]